All In MedTech

Device Trial Radar · NCT07060547

Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Jun 10, 2025

Primary completion

Dec 2031

Study completion Mar 2032

Sponsor

Lead sponsor
HepQuant, LLCNot on our public-company list
Sponsor type
Industry
Collaborators
Leland Stanford Junior University
First posted
Jul 11, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At each of these visits, participants will undergo a HepQuant DuO test and other standard tests. In addition, the study team will ask about a participant's alcohol use, symptoms, and quality of life.

Conditions

  • Alcoholic Hepatitis
  • Alcohol-related Liver Disease

Interventions

  • HepQuant DuO TestDevice

    HepQuant DuO is commercially available in the U.S. as a Laboratory Developed Test (LDT), but it will be used in this study as a nonsignificant risk investigational device to measure change in liver function over time.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in HepQuant Disease Severity Index (DSI) over time in patients with ALDTime frame: From enrollment to 1 year past enrollment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stanford University Dept. of Medicine -Gastroenterology & Hepatology

    Redwood City, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.